🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the efficacy and safety of long...
Status
Completed
Location
Kameda Medical Center
Start Date
2018-02-18
Trial ID
NCT03416374
Treatments Being Tested
This randomized phase III trial compares ixazomib citrate, lenalidomide, de...
Status
Terminated
Location
Anchorage Associates in Radiation Medicine
Start Date
2016-11-29
Trial ID
NCT02516423
Treatments Being Tested
The primary purpose of this study is to determine the overall response rate...
Status
Withdrawn
Location
CEHON Centro de Hematologia e Oncologia da Bahia
Start Date
2019-09-30
Trial ID
NCT03608501
Treatments Being Tested
This research is being done to assess the effectiveness and safety of the c...
Status
Terminated
Location
Massachusetts General Hospital Cancer Center
Start Date
2020-02-14
Trial ID
NCT04119336
Treatments Being Tested
This is a Phase I/II study using the combination of twice weekly ixazomib p...
Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Start Date
2019-09-18
Trial ID
NCT04094961
Treatments Being Tested
The purpose of this study is to see what effects, good and/or bad, the comb...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2016-02
Trial ID
NCT02697383
Treatments Being Tested
This phase II trial studies how well abatacept, ixazomib citrate, and dexam...
Status
Terminated
Location
Roswell Park Cancer Institute
Start Date
2018-09-11
Trial ID
NCT03457142
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Withdrawn
Location
University of Mississippi Medical Center
Start Date
2020-10-31
Trial ID
NCT03888534
Treatments Being Tested
Trial Title: FiTNEss (UK-MRA Myeloma XIV) - Frailty-adjusted therapy in Tr...
Status
Unknown
Location
Aberdeen Royal Infirmary
Start Date
2020-08-04
Trial ID
NCT03720041
Newly Diagnosed Myeloma Patients, who achieved efficacy above VGPR (very go...
Status
Unknown
Location
shanghai Jiaotong University School of Medicine, Renji Hospital
Start Date
2023-02-16
Trial ID
NCT05477797
Treatments Being Tested